What is known about tezepelumab passing into human breast milk?

Whether tezepelumab passes into human milk is unknown; human IgGs enter milk particularly during the first few days after birth, when infant risk cannot be excluded and treatment interruption should be considered against breastfeeding and maternal treatment benefits, whereas afterwards tezepelumab could be used if clinically needed.